Vanguard Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.76M Sell
2,751,818
-219,780
-7% -$420K ﹤0.01% 3101
2026
Q2
$5.91M Buy
2,971,598
+85,945
+3% +$124K ﹤0.01% 3055
2026
Q1
$3.66M Buy
+2,885,653
New +$5.43M ﹤0.01% 3170

Other funds holding HCAT

Vanguard Capital Management's HCAT Position: Q3 2026 in Review

Vanguard Capital Management reduced its Health Catalyst (HCAT) stake by 7.4% in Q3 2026, selling an estimated $420K and leaving 2,751,818 shares worth $4.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

Vanguard Capital Management first reported a position in HCAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.91M in Q2 2026. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Vanguard Capital Management held 2,751,818 shares of Health Catalyst worth $4.76M as of Q3 2026.
  • Vanguard Capital Management sold 219,780 Health Catalyst shares in Q3 2026, an estimated $420K.
  • Health Catalyst made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3101 holding.
  • Vanguard Capital Management first reported a position in Health Catalyst in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Health Catalyst position peaked at $5.91M in Q2 2026.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.